Overview
Shiitake mushrooms are the second most commonly eaten mushrooms in the world. Lentinan and other chemicals in shiitake mushrooms might stimulate the immune system.
People use shiitake mushroom or an extract called AHCC for HIV/AIDS, common cold, flu, and many other conditions, but there is no good scientific evidence to support these uses. There is also no good evidence to support using shiitake mushroom for COVID-19.
Uses & Effectiveness ?
Possibly Ineffective for
Side Effects
Special Precautions and Warnings
Pregnancy and breast-feeding: There isn't enough reliable information to know if shiitake mushroom is safe to use when pregnant or breast-feeding. Stay on the safe side and stick to food amounts.
"Auto-immune diseases" such as multiple sclerosis (MS), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), or other conditions: Shiitake mushroom might cause the immune system to become more active. This could increase the symptoms of auto-immune diseases. If you have one of these conditions, it's best to avoid using shiitake mushroom.
A blood disorder called hypereosinophilic syndrome: Don't use shiitake mushroom if you have this condition. It might make it worse.
Interactions ?
Medications that decrease the immune system (Immunosuppressants) interacts with SHIITAKE MUSHROOM
Shiitake mushroom can increase the activity of the immune system. Some medications, such as those used after a transplant, decrease the activity of the immune system. Taking shiitake mushroom along with these medications might decrease the effects of these medications.
Medications changed by the liver (Cytochrome P450 2D6 (CYP2D6) substrates) interacts with SHIITAKE MUSHROOM
Some medications are changed and broken down by the liver. Shiitake mushroom might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.
Moderate Interaction
Be cautious with this combination
Dosing
Amino, M., Noguchi, R., Yata, J., Matsumura, J., Hirayama, R., Abe, O., Enomoto, K., and Asato, Y. [Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients]. Gan To Kagaku Ryoho 1983;10(9):2000-2006. View abstract.
Arinaga, S., Karimine, N., Takamuku, K., Nanbara, S., Nagamatsu, M., Ueo, H., and Akiyoshi, T. Enhanced production of interleukin 1 and tumor necrosis factor by peripheral monocytes after lentinan administration in patients with gastric carcinoma. Int.J.Immunopharmacol. 1992;14(1):43-47. View abstract.
Aviles, H., Belay, T., Vance, M., Sun, B., and Sonnenfeld, G. Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions. J Appl.Physiol 2004;97(4):1437-1444. View abstract.
Aviles, H., O'Donnell, P., Orshal, J., Fujii, H., Sun, B., and Sonnenfeld, G. Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection. Am J Surg. 2008;195(4):537-545. View abstract.
Aviles, H., O'Donnell, P., Sun, B., and Sonnenfeld, G. Active hexose correlated compound (AHCC) enhances resistance to infection in a mouse model of surgical wound infection. Surg.Infect.(Larchmt.) 2006;7(6):527-535. View abstract.
Badawi, T. A., Khalil, N. A., Abdelrahman, A. H., and Aly, Z. H. Immunoprophylactic Effect of Active Hexose Correlated Compound on Normal and Induced Submandibular Salivary Gland Neoplasm in Albino Rats. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Burikhanov, R. B., Wakame, K., Igarashi, Y., Wang, S., and Matsuzaki, S. Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat. Endocr.Regul. 2000;34(4):181-188. View abstract.
Cao, Z., Lin, W., Chen, R., Chen, X., Liao, L., and Ou, J. The Preliminary Study of AHCC Freeze-dried Powder and AHCC Serum on Proliferation and Apoptosis of Hepatoma Cell Line. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Chutaputthi, A. Pilot Study of AHCC on HBeAg Level in CHBeAg Positive Patients on Long Term Anti-viral Treatment. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Cowawintaweewat, S., Manoromana, S., Sriplung, H., Khuhaprema, T., Tongtawe, P., Tapchaisri, P., and Chaicumpa, W. Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment. Asian Pac.J Allergy Immunol. 2006;24(1):33-45. View abstract.
Curnow, P. and Tam, M. Contact dermatitis to Shiitake mushroom. Australas.J.Dermatol. 2003;44(2):155-157. View abstract.
Daddaoua, A., Martinez-Plata, E., Lopez-Posadas, R., Vieites, J. M., Gonzalez, M., Requena, P., Zarzuelo, A., Suarez, M. D., de Medina, F. S., and Martinez-Augustin, O. Active hexose correlated compound acts as a prebiotic and is antiinflammatory in rats with hapten-induced colitis. J Nutr. 2007;137(5):1222-1228. View abstract.
Daddaoua, A., Martinez-Plata, E., Ortega-Gonzalez, M., Ocon, B., Aranda, C. J., Zarzuelo, A., Suarez, M. D., de Medina, F. S., and Martinez-Augustin, O. The nutritional supplement Active Hexose Correlated Compound (AHCC) has direct immunomodulatory actions on intestinal epithelial cells and macrophages involving TLR/MyD88 and NF-kappaB/MAPK activation. Food Chem. 2-15-2013;136(3-4):1288-1295. View abstract.
Drannik, A. G., Kurchenko, A. I., Savchenko, V. S., and Drannik, G. N. AHCC Induces in vitro Functional Activity ofPBMC-derived Mononuclear Cells from Subjects with Recurring Herpes Simplex Type 1 and 2 Infections. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
Du, J. Anti-tumor Effects of AHCC in H22 Tumor-bearing ICR Mice and BALB/c Nude Mice. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
Du, J. Effect of AHCC for Peripheral Blood VEGF in Hepatocarcinoma-Inoculated Mice. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
Enman, J., Rova, U., and Berglund, K. A. Quantification of the bioactive compound eritadenine in selected strains of shiitake mushroom (Lentinus edodes). J Agric Food Chem 2-21-2007;55(4):1177-1180. View abstract.
Fruehauf, J. P., Bonnard, G. D., and Herberman, R. B. The effect of lentinan on production of interleukin-1 by human monocytes. Immunopharmacology 1982;5(1):65-74. View abstract.
Fujii, H., Nishioka, H., Wakame, K., and Sun, B. Nutritional Food Active Hexose Correlated Compound (AHCC) Enhances Resistance Against Bird Flu. Japanese Journal of Complimentary and Alt.Medicine 2007;4(2):37-39.
Fujii, H., Nishioka, N., Simon, R. R., Kaur, R., Lynch, B., and Roberts, A. Genotoxicity and subchronic toxicity evaluation of Active Hexose Correlated Compound (AHCC). Regul.Toxicol.Pharmacol. 2011;59(2):237-250. View abstract.
Fujiwara, K., Sato, T., Yonei, T., Genba, K., Nogami, N., and Yamadori, I. [A case of chronic hypersensitivity pneumonitis induced by shiitake mushroom spores]. Nihon Kokyuki.Gakkai Zasshi 2000;38(12):908-913. View abstract.
Gao, Y., Zhang, D., Sun, B., Fujii, H., Kosuna, K., and Yin, Z. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol.Immunother. 2006;55(10):1258-1266. View abstract.
Gardner, E. AHCC Supplementation of Energy-restricted Mice May Improve Natural Killer Cell Function during Primary Influenza Infection. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Ghoneum, M. NK-Immunomodulation by Active Hemicellulose Compound (AHCC) in 17 Cancer Patients. 2nd Meeting of the Society for Natural Immunity 1994.
Ghoneum, M., Wimbley, M., Salem, F., McKlain, A., Attallah, N., and Gill, G. Immunomodulatory and anticancer effects of active hexose correlated compound (AHCC). Int J Immunother 1995;11:23-28.
Gu, Y. H. and Belury, M. A. Selective induction of apoptosis in murine skin carcinoma cells (CH72) by an ethanol extract of Lentinula edodes. Cancer Lett 3-18-2005;220(1):21-28. View abstract.
Haidari, M., Zhang, W., and Chen, Z. Active Hexose Correlated Compound (AHCC) Inhibits Disruption of Endothelial Adherens Junction Induced by High Concentration of Glucose. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Haidari, M., Zhang, W., Chen, Z., Ganjehei, L., Mortazavi, A., and Dixon, R. AHCC Attenuates Cytokine-induced Attachment of invasive Cancer Cells to Endothelial Cells. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
Haidari, M., Zhang, W., Chen, Z., Ganjehei, L., Mortazavi, A., and Dixon, R. AHCC Protects Endothelial Cells against Disruption of Adherens Junction by Pro-inflammatory Stimuli [General Lecture]. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
Hamano, K., Gohra, H., Katoh, T., Fujimura, Y., Zempo, N., and Esato, K. The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary bypass. Int.J.Immunopharmacol. 1999;21(8):531-540. View abstract.
Hanaue, H., Tokuda, Y., Machimura, T., Kamijoh, A., Kondo, Y., Ogoshi, K., Makuuchi, H., Nakasaki, H., Tajima, T., Mitomi, T., and . Effects of oral lentinan on T-cell subsets in peripheral venous blood. Clin Ther 1989;11(5):614-622. View abstract.
Hatvani, N. Antibacterial effect of the culture fluid of Lentinus edodes mycelium grown in submerged liquid culture. Int.J.Antimicrob.Agents 2001;17(1):71-74. View abstract.
Hayama, K., Yamazaki, M., and Abe, S. Protective Activity of Combination of AHCC and UREX against Murine Vaginal Candidiasis. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012;
Hazama, S., Oka, M., Yoshino, S., Iizuka, N., Wadamori, K., Yamamoto, K., Hirazawa, K., Wang, F., Ogura, Y., Masaki, Y., and . [Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma]. Gan To Kagaku Ryoho 1995;22(11):1595-1597. View abstract.
Herlyn, D., Kaneko, Y., Powe, J., Aoki, T., and Koprowski, H. Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan. Jpn.J.Cancer Res. 1985;76(1):37-42. View abstract.
Hibino, Y., Konishi, Y., Koike, J., Tabata, T., Ohashi, Y., and Sugano, N. Productions of interferon-gamma and nitrite are induced in mouse splenic cells by a heteroglycan-protein fraction from culture medium of Lentinus edodes mycelia. Immunopharmacology 1994;28(1):77-85. View abstract.
Hirooka, S., Yanagimoto, H., Satoi, S., Toyokawa, H., Yamamoto, T., Yui, R., Yamaki, S., Michiura, T., Inoue, K., and Kwon, A. Effect of Administration of AHCC in Rat with Subcutaneous Tumor of Pancreatic Cancer Cell. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Hisajima, T., Maruyama, N., Funakoshi, K., and Abe, S. Effect of AHCC on the Mucosal Immune System of the Mice with Intestinal Candidiasis. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
Hong, S. J., Chung, B. H., Kim, J. S., Lee, M. J., Yoon, S., Oh, H. Y., Lee, E. J., Lim, H. G., and Buxiang, S. The effects of GAC on the biochemical profiles and quality of life of metastatic prostate cancer patients. Korean Journal of Urology 2006;47(5):467-474.
Horiguchi, M., Saito, A., and Sonoda, H. [A gastric cancer showing marked improvement (stage IV) with lentinan immunotherapy and 5-FU, MMC-chemotherapy]. Gan To Kagaku Ryoho 1988;15(6):1973-1977. View abstract.
Hunter, R. J., Fujii, H., Wakame, K., Gaikwad, A., Wolf, J. K., and Smith, J. A. Evaluation of active hexose correlated compound (AHCC) in combination with pegylated liposomal doxorubicin for treatment of ovarian cancer. International Journal of Applied Research in Natural Products 2011;4(3):6-14.
Inagaki, T., Morise, K., and Matsunaga, H. [Effects of endoscopic intratumoral injection of lentinan in patients with gastric cancer]. Gan To Kagaku Ryoho 1988;15(2):319-324. View abstract.
Ishibashi, H., Hirakawa, K., Nakajima, H., Ioka, J., Shirono, K., Tanabe, S., Ochiai, K., Tomita, K., and Kitagawa, Y. [A case of gastric cancer with peritonitis carcinomatosa which improved upon oral administration of UFT, mitomycin C and lentinan]. Gan To Kagaku Ryoho 1987;14(9):2787-2791. View abstract.
Jiang, S., Nakano, T., Nishizawa, M., and Kimura, T. Effect of AHCC on IFN-al Antisense RNA and mRNA Expression Levels in the Respiratory Tract of Influenza Virus AlPR/8/34-infected Guinea Pigs. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012;
Jones, K. Shiitake: A Major Medicinal Mushroom. Alternative and Complementary Therapies 1998;4(1):53-59.
Kan, N., Kodama, H., Hori, T., Takenaka, A., Yasumura, T., Kato, H., Ogawa, H., Ohsumi, K., Kudo, N., Mukaihara, S., and . [Intrapleural treatment of breast cancer patients with pleural effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast Cancer Study Group]. Gan To Kagaku Ryoho 1992;19(10 Suppl):1632-1635. View abstract.
Karkow, A. and Karkow, F. AHCC: A Personal Experience. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Kawaguchi, Y. Improved Survival of Patients with Gastric Cancer or Colon Cancer when treated with Active Hexose Correlated Compound (AHCC): Effect of AHCC on digestive system cancer. Nautral Medicine Journal 2009;1(1):1-6.
Kidd, P. M. The use of mushroom glucans and proteoglycans in cancer treatment. Altern.Med Rev. 2000;5(1):4-27. View abstract.
Kim, J. The Effect of AHCC in non-viral, chronic and abnormal liver function condition: a randomized, double-blind, placebo-control study. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
Kulkarni, A. Dietary AHCC in Acute Gut Injury Model. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
Kunitomo, K., Kawahito, M., Miura, M., and Komi, N. [Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation--a case of long-term survival of pancreas cancer after palliative surgery]. Gan To Kagaku Ryoho 1987;14(5 Pt 1):1342-1344. View abstract.
Kurokawa, T. Use of AHCC in Multimodality Therapy against Advanced or Terminal Cancer. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
Kuznetsov, O. I., Mil'kova, E. V., Sosnina, A. E., and Sotnikova, N. I. [Antimicrobial action of Lentinus edodes juice on human microflora]. Zh.Mikrobiol.Epidemiol.Immunobiol. 2005;(1):80-82. View abstract.
Ladanyi, A., Timar, J., and Lapis, K. Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells. Cancer Immunol.Immunother. 1993;36(2):123-126. View abstract.
Lee, W. W. and Kang, I. Investigating the Effect of AHCC and a-Glucan on IL-IP and IL-6 Production from Human Monocytes. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
Lee, W. W., Lee, N., Fujii, H., and Kang, I. Active Hexose Correlated Compound promotes T helper (Th) 17 and 1 cell responses via inducing IL-1beta production from monocytes in humans. Cell Immunol. 2012;275(1-2):19-23. View abstract.
Lee, W. W., Shin, M. S., and Kang, I. AHCC Induces Production ofIL-17 from CD4+ T Cells via Stimulating Monocytes in Humans. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
Li, J. F., Guo, J. W., and Huang, X. F. [Study on the enhancing effect of polyporus polysaccharide, mycobacterium polysaccharide and lentinan on lymphokine-activated killer cell activity in vitro]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1996;16(4):224-226. View abstract.
Lippert, U., Martin, V., Schwertfeger, C., Junghans, V., Ellinghaus, B., and Fuchs, T. Shiitake dermatitis. Br.J Dermatol. 2003;148(1):178-179. View abstract.
Liu, M., Li, J., Kong, F., Lin, J., and Gao, Y. Induction of immunomodulating cytokines by a new polysaccharide-peptide complex from culture mycelia of Lentinus edodes. Immunopharmacology 1998;40(3):187-198. View abstract.
Lobanok, A. G., Babitskaia, V. G., Plenina, L. V., Puchkova, T. A., and Osadchaia, O. V. [Composition and biological activity of submerged mycelium of the xylotrophic basidiomycete Lentinus edodes]. Prikl.Biokhim.Mikrobiol. 2003;39(1):69-73. View abstract.
Luo, A., Zhang, K., Wakame, K., and Kulkarni, A. Dietary Active Hexose Correlated Compound (AHCC) Decreases Ischemial Reperfusion Injury [General Lecture]. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
Mach, C. M., Fugii, H., Wakame, K., and Smith, J. Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents. J Soc Integr.Oncol. 2008;6(3):105-109. View abstract.
Maekawa, S., Saku, M., Kinugasa, T., Yoshida, Y., Ikejiri, K., and Yakabe, S. [A case report of advanced gastric cancer remarkably responding to mitomycin C, aclacinomycin A, SF-SP and lentinan combination therapy]. Gan To Kagaku Ryoho 1990;17(1):137-140. View abstract.
Mak, R. K. and Wakelin, S. H. Shiitake dermatitis: the first case reported from a European country. Br J Dermatol 2006;154(4):800-801. View abstract.
Mashiko, H., Satoh, J., Hatayama, H., and Kitamura, H. [A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan]. Gan To Kagaku Ryoho 1992;19(5):715-718. View abstract.
Masuyama, T., Mizuishi, Y., Moriyama, A., Takeshita, K., Takahashi, T., and Kuwabara, M. Application of New Immunotherapy Using AHCC for Animal Disease. Presented at the 8th International Congress on Nutrition and Integrative Medicine (ICNIM) 2000;
Matsui, K., Kawaguchi, Y., Ozaki, T., Tokuhara, K., Tanaka, H., Kaibori, M., Matsui, Y., Kamiyama, Y., Wakame, K., Miura, T., Nishizawa, M., and Okumura, T. Effect of active hexose correlated compound on the production of nitric oxide in hepatocytes. JPEN J Parenter.Enteral Nutr. 2007;31(5):373-380. View abstract.
Matsui, Y., Uhara, J., Satoi, S., Kaibori, M., Yamada, H., Kitade, H., Imamura, A., Takai, S., Kawaguchi, Y., Kwon, A. H., and Kamiyama, Y. Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study. J Hepatol. 2002;37(1):78-86. View abstract.
Matsuoka, H., Yano, K., Seo, Y., Saito, T., Tomoda, H., and Tsurumoto, S. Usefulness of lymphocyte subset change as an indicator for predicting survival time and effectiveness of treatment with the immunopotentiator lentinan. Anticancer Res. 1995;15(5B):2291-2296. View abstract.
Mio, H. and Terabe, K. [Clinical effects of postoperative immunochemotherapy with a combination of 5-FU, CDDP and lentinan for stage IVb gastric carcinoma and long-term pharmacokinetic studies on CDDP and 5-FU]. Gan To Kagaku Ryoho 1997;24(3):337-342. View abstract.
Mio, H. and Terabe, K. [Postoperative immunochemotherapy for gastric carcinoma with peritoneal dissemination--the effects with the combination of CDDP, 5-FU and lentinan]. Gan To Kagaku Ryoho 1994;21(4):531-534. View abstract.
Miyakoshi, H., Aoki, T., and Mizukoshi, M. Acting mechanisms of Lentinan in human--II. Enhancement of non-specific cell-mediated cytotoxicity as an interferon inducer. Int.J.Immunopharmacol. 1984;6(4):373-379. View abstract.
Miyamoto, K., Inagaki, Y., and Miyairi, M. [Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report]. Nippon Gan Chiryo Gakkai Shi 12-20-1989;24(11):2624-2628. View abstract.
Mizuno, T. Shiitake, Lentinus edodes: functional properties for medicinal and food purposes. Food Rev.Int. 1995;11:111-128.
Mukoda, S., Kosuna, K., and Okada, F. Reduction of side affects of anticancer drugs by active hexose correlated compound (AHCC). Proceedings of the American Association for Cancer Research 1999;40.
Nagahashi, S., Suzuki, H., Nishiwaki, M., Okuda, K., Kurosawa, Y., Terada, S., Sugihara, T., Andou, K., and Hibi, T. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer]. Gan To Kagaku Ryoho 2004;31(12):1999-2003. View abstract.
Nakano, H., Namatame, K., Nemoto, H., Motohashi, H., Nishiyama, K., and Kumada, K. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group. Hepatogastroenterology 1999;46(28):2662-2668. View abstract.
Nakano, H., Namatame, K., Nemoto, H., Motohashi, H., Nishiyama, K., and Kumada, K. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group. Hepatogastroenterology 1999;46(28):2662-2668. View abstract.
Nakayama, H., Aoki, N., Hayashi, S., Wakabayashi, K., Karube, H., Ogame, H., Aoki, H., Sakamoto, N., Masuda, H., and Hemmi, A. [A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma]. Gan To Kagaku Ryoho 2004;31(2):241-243. View abstract.
Nanba, H., Mori, K., Toyomasu, T., and Kuroda, H. Antitumor action of shiitake (Lentinus edodes) fruit bodies orally administered to mice. Chem Pharm Bull.(Tokyo) 1987;35(6):2453-2458. View abstract.
Ng, M. L. and Yap, A. T. Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes). J Altern.Complement Med. 2002;8(5):581-589. View abstract.
Ngai, P. H. and Ng, T. B. Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemia cells. Life Sci 11-14-2003;73(26):3363-3374. View abstract.
Nimura, H., Mitsumori, N., Takahashi, N., Kashimura, H., Takayama, S., Kashiwagi, H., and Yanaga, K. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer]. Gan To Kagaku Ryoho 2006;33 Suppl 1:106-109. View abstract.
Nimura, H., Mitsumori, N., Tsukagoshi, S., Nakajima, M., Atomi, Y., Suzuki, S., Kusano, M., Yoshiyuki, T., and Tokunaga, A. [Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer]. Gan To Kagaku Ryoho 2003;30(9):1289-1296. View abstract.
Ning, J., Zhang, W., Yi, Y., Yang, G., Wu, Z., Yi, J., and Kong, F. Synthesis of beta-(1-->6)-branched beta-(1-->3) glucohexaose and its analogues containing an alpha-(1-->3) linked bond with antitumor activity. Bioorg.Med Chem 5-15-2003;11(10):2193-2203. View abstract.
Nishioka, H. Preventive effect of AHCC for avian influenza virus. 15th International Symposium of the AHCC Research Association 2007.
Nogusa, S., Gerbino, J., and Ritz, B. W. Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice. Nutr.Res 2009;29(2):139-143. View abstract.
Nomura, T., Adachi, S., Ryo, H., Kikuya, R., Hatanaka, E., Tokita, Y., Nakajima, H., Hongyo, T., and Parida, D. K. Prevention of Cancer and Malformation by Active Hexose Correlated Compound (AHCC) in Mice and Humans. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
Nomura, T., Nakajima, H., Hongyo, T., Kikuya, R., Adachi, S., Ryo, H., Tokita, Y., Eiko, H., Yoshida, N., Parida, D. K., and Wakame, K. Inhibition of Radiation Induced Late Effects (Congenital Malformations and Leukemia) by Active Hexose Correlated Compound, AHCC in Mice. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
Ocon, B., Anzola, A., Ortega, M., Zarzuelo, A., Suarez, M. D., de Medina, F. S., and Augustin, O. M. Active Hexose Correlated Compound and Bifidobacterium Longum Exert Symbiotic Effects in Experimental Colitis. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
Ocon, B., Anzola, A., Ortega-Gonzalez, M., Zarzuelo, A., Suarez, M. D., Sanchez de, Medina F., and Martinez-Augustin, O. Active hexose-correlated compound and Bifidobacterium longum BB536 exert symbiotic effects in experimental colitis. Eur.J Nutr 2013;52(2):457-466. View abstract.
Oka, M., Yoshino, S., Hazama, S., Shimoda, K., and Suzuki, T. Immunological analysis and clinical effects of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion. Biotherapy 1992;5(2):107-112. View abstract.
Okumura, T., Matsumyia, M., Araki, Y., Matsuura, T., Kaibori, M., Kwon, A., Nishioka, H., Shigama, K., Nakamoto, D., Yoshigai, E., Hara, T., and Nishizawa, M. Effect of AHCC on the Induction of iNOS and Proinflammatory Cytokines in LPS-Treated Mice. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
Okuyama, K., Isono, K., Satoh, H., Onoda, S., Ochiai, T., Hayashi, R., Tohnosu, N., Yamamoto, Y., Chin, F., Kimura, M., Ryu, M., Kohzu, T., Odaka, M., and Satoh, H. [Effect of continuous intra-arterial infusion therapy with BLM-MMC-lentinan (B-M-L) in treating patients with hepatic metastases of esophageal cancer]. Nippon Gan Chiryo Gakkai Shi 10-20-1982;17(7):1895-1901. View abstract.
Parida, D. K., Wakame, K., and Nomura, T. Integrating Complimentary and Alternative Medicine in Form of Active Hexose Correlated Compound (AHCC) in the Management of Head & Neck Cancer Patients. International Journal of Clinical Medicine 2011;2:588-592.
Peter, G., Karoly, V., Imre, B., Janos, F., and Kaneko, Y. Effects of lentinan on cytotoxic functions of human lymphocytes. Immunopharmacol.Immunotoxicol. 1988;10(2):157-163. View abstract.
Ritz, B. W. Supplementation with active hexose correlated compound increases survival following infectious challenge in mice. Nutr.Rev. 2008;66(9):526-531. View abstract.
Ritz, B. W., Nogusa, S., Ackerman, E. A., and Gardner, E. M. Supplementation with active hexose correlated compound increases the innate immune response of young mice to primary influenza infection. J Nutr. 2006;136(11):2868-2873. View abstract.
Roman, B. E., Beli, E., Duriancik, D. M., and Gardner, E. M. Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine. Nutr Res. 2013;33(1):12-17. View abstract.
Sakaguchi, T., Ishizaki, M., Kaibori, M., Matsui, K., Hirooka, S., Tsuda, T., Matsushima, H., Matsui, Y., and Kwon, A. Complete Response of Advanced Hepatocellular Carcinoma Using AHCC in Multimodality Therapy. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Sakamaki, S., Kohgo, Y., Suzuki, M., Ogiwara, R., Suga, T., Kondo, N., Izawa, M., Kanisawa, Y., and Niitsu, Y. Individual diversity of IL-6 generation by human monocytes with lentinan administration. Int.J.Immunopharmacol. 1993;15(6):751-756. View abstract.
Sanchez de Medina, F., Plata, E. M., Romero-Calvo, I., Ortega, M., Gonzalez, R., Daddaoua, A., Martinez-Moya, P., Zarzuelo, A., Suarez, M. D., and Martinez-Augustin, O. Correlated Compound Exerts Immunomodulatory Effects and Induces Differentiation in Several Intestinal Cell Types that are Independent on their Prebiotic Actions. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
Sano, T., Nomura, K., Adachi, M., and Kobori, O. [An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy]. Gan No Rinsho 1990;36(1):97-100. View abstract.
Sasaki, S., Okawa, H., and Nishioka, H. Activation of Macrophages and Lymphocytes by AHCC-containing Liquid Product. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
Sastre, J., Ibanez, M. D., Lopez, M., and Lehrer, S. B. Respiratory and immunological reactions among Shiitake (Lentinus edodes) mushroom workers. Clin.Exp.Allergy 1990;20(1):13-19. View abstract.
Shimizu, H., Inoue, M., Shimizu, C., Saito, J., Ueda, G., and Tanizawa, O. Augmentation of antitumor effect of recombinant interleukin-2 activated killer cells by the administration of rIL-2 and lentinan. Nippon Sanka Fujinka Gakkai Zasshi 1988;40(12):1899-1900. View abstract.
Shimizu, Y., Chen, J. T., Shiokawa, S., Nakayama, K., Yokosuka, K., Teshima, H., Hirai, Y., Hamada, T., Yamauchi, K., Fujimoto, I., and . [Antigenic phenotype of the lymphocytic component of regional lymph nodes in patients with cervical cancer and its modulation by lentinan]. Nippon Sanka Fujinka Gakkai Zasshi 1990;42(1):37-44. View abstract.
Shimizu, Y., Hasumi, K., Chen, J. T., Hirai, Y., Nakayama, K., Teshima, H., Hamada, T., Fujimoto, I., Yamauchi, K., and Masubuchi, K. [Successful treatment of a patient with recurrent ovarian cancer by lentinan combined with intraarterial 5FU]. Nippon Gan Chiryo Gakkai Shi 3-20-1989;24(3):647-651. View abstract.
Sia, G. M. and Candlish, J. K. Effects of shiitake (Lentinus edodes) extract on human neutrophils and the U937 monocytic cell line. Phytother.Res. 1999;13(2):133-137. View abstract.
Sipka, S., Abel, G., Csongor, J., Chihara, G., and Fachet, J. Effect of lentinan on the chemiluminescence produced by human neutrophils and the murine macrophage cell line C4M phi. Int.J.Immunopharmacol. 1985;7(5):747-751. View abstract.
Smith, J. A., Gaikwad, A., Jaffari, M., Frumovitz, M., and Meyer, L. Evaluation of Active Hexose Correlated Compound (AHCC) for the Prevention or Delay of Tumor Growth in Human Cervical Cancer Xenograft Model. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Smith, J. A., Hunter, R. J., Fujii, H., Wakame, K., and Wolf, J. Defining Synergistic Activity ofthe Combination of Active Hexose Correlated Compound (AHCC) with Liposomal Doxorubicin (Doxil). Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
Spierings, E. L., Fujii, H., Sun, B., and Walshe, T. A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers. J Nutr Sci Vitaminol.(Tokyo) 2007;53(6):536-539. View abstract.
Suga, T., Shiio, T., Maeda, Y. Y., and Chihara, G. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Cancer Res 1984;44(11):5132-5137. View abstract.
Sula, J. Our Experience in Measuring the Increased Activity of Properdin in Patients with Cancer after Using AHCC for Six Months. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
Sumiyoshi, Y., Hashine, K., Kakehi, Y., Yoshimura, K., Satou, T., Kuruma, H., Namiki, S., and Shinohara, N. Dietary administration of mushroom mycelium extracts in patients with early stage prostate cancers managed expectantly: a phase II study. Jpn.J Clin.Oncol. 2010;40(10):967-972. View abstract.
Sun, B., Mukoda, T., Miura, T., Fujii, H., Yuan, L., and White, R. Anti-tumor Effects of Genistein Combined Polysaccharide (GCP) and Active Hexose Correlated Compound (AHCC). Translated. Biotherapy 2001;15(3):379-382.
Sun, B., Wakame, K., Mukoda, T., Toyoshima, A., Kanazawa, T., and Kosuna, K. Preventive effects of AHCC on carbon tetrachloride induced liver injury in mice. Nautral Medicine 1997;51(4):310-315.
Sun, B., Wakame, K., Sato, E., Nishioka, H., Aruoma, O. I., and Fujii, H. The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents. Cancer Epidemiol. 2009;33(3-4):293-299. View abstract.
Sundaresan, A., Wakame, K., and Kulkarni, A. D. AHCC Positively Regulates Liver Metabolism by Diminishing Oxidative Stress and Protects the Heart by Increasing Liver Trafficking of LDL. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Suzuki, H., Iiyama, K., Yoshida, O., Yamazaki, S., Yamamoto, N., and Toda, S. Structural characterization of the immunoactive and antiviral water-solubilized lignin in an extract of the culture medium of Lentinus edodes mycelia (LEM). Agric.Biol Chem 1990;54(2):479-487. View abstract.
Taguchi, T. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer]. Gan To Kagaku Ryoho 1983;10(2 Pt 2):387-393. View abstract.
Taguchi, T., Furue, H., Kimura, T., Kondo, T., Hattori, T., Itoh, I., and Ogawa, N. [Results of phase III study of lentinan]. Gan To Kagaku Ryoho 1985;12(2):366-378. View abstract.
Takahashi, T., Hori, Y., Isogawa, S., Saho, M., Yoshida, H., Yokoyama, K., Watanabe, M., and Nakagawa, S. [A case of hepatocellular carcinoma in an elderly patient that improved upon combination therapy of Lentinan and Tegafur]. Gan To Kagaku Ryoho 1990;17(8 Pt 1):1517-1519. View abstract.
Takemura, T., Takahashi, S., Yoshikawa, T., and Kondo, M. [A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan]. Gan To Kagaku Ryoho 2000;27(1):107-111. View abstract.
Takeshita, K., Hayashi, S., Tani, M., Kando, F., Saito, N., and Endo, M. Monocyte function associated with intermittent lentinan therapy after resection of gastric cancer. Surg.Oncol. 1996;5(1):23-28. View abstract.
Takeshita, K., Saito, N., Sato, Y., Maruyama, M., Sunagawa, M., Habu, H., and Endo, M. [Diversity of complement activation by lentinan, an antitumor polysaccharide, in gastric cancer patients]. Nippon Geka Gakkai Zasshi 1991;92(1):5-11. View abstract.
Takeshita, K., Watanuki, S., Iida, M., Saito, N., Maruyama, M., Sunagawa, M., Habu, H., and Endo, M. Effect of lentinan on lymphocyte subsets of peripheral blood, lymph nodes, and tumor tissues in patients with gastric cancer. Surg.Today 1993;23(2):125-129. View abstract.
Takeshita, M., Kobori, T., Sudo, E., Miyamoto, Y., and Izuo, M. [Preoperative immunochemotherapy for gastric cancer patients--immunomodulating effect of levamisole and lentinan on cell-mediated immunity and regional lymph node]. Gan To Kagaku Ryoho 1982;9(6):1052-1060. View abstract.
Takita, M., Onda, M., Tokunaga, A., Shirakawa, T., Ikeda, K., Hiramoto, Y., Teramoto, T., Oguri, T., Fujita, I., Okuda, T., Mizutani, T., Kiyama, T., Yoshiyuki, T., and Matsukura, N. [Successful treatment of hepatic metastasis of gastric cancer with 5'-DFUR and Lentinan]. Gan To Kagaku Ryoho 1998;25(1):129-133. View abstract.
Tanabe, H., Imai, N., and Takechi, K. [Studies on usefulness of postoperative adjuvant chemotherapy with lentinan in patients with gastrointestinal cancer]. Nippon Gan Chiryo Gakkai Shi 8-20-1990;25(8):1657-1667. View abstract.
Tanaka, Y., Ohashi, S., Sato, K., Miki, H., Oishi, M., Tokuhara, K., Kaibori, M., Okumura, T., Nishizawa, M., and Kwon, A. H. Adenosine, a Hepato-protective Compound in AHCC. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Tani, M., Tanimura, H., Yamaue, H., Tsunoda, T., Iwahashi, M., Noguchi, K., Tamai, M., Hotta, T., and Mizobata, S. Augmentation of lymphokine-activated killer cell activity by lentinan. Anticancer Res. 1993;13(5C):1773-1776. View abstract.
Tensho, A., Shimizu, I., Takenawa, T., Kikuchi, H., and Rokujo, T. [Hypocholesterolemic activity of analogous compounds related to eritadenine, an active component of shiitake, Lentinus edodes Sing (author's transl)]. Yakugaku Zasshi 1974;94(6):708-716. View abstract.
Terakawa, N., Matsui, Y., Satoi, S., Yanagimoto, H., Takahashi, K., Yamamoto, T., Yamao, J., Takai, S., Kwon, A. H., and Kamiyama, Y. Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. Nutr.Cancer 2008;60(5):643-651. View abstract.
Thaiudom, S., Piyaniran, W., and Chutaputthi, A. A study of the efficacy of Active Hexose Correlated Compound (AHCC) in the treatment of chronic Hepatitis C patients at Phramongkutklao Hospital. The Medical News (Thailand) 2010;325:13-16.
Tochikura, T. S., Nakashima, H., Ohashi, Y., and Yamamoto, N. Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia. Med.Microbiol.Immunol.(Berl) 1988;177(5):235-244. View abstract.
Uno, K., Kosuna, K., Sun, B., Fujii, H., Wakame, K., Chikumaru, S., Hosokawa, G., and Ueda, Y. Active Hexose Correlated Compound (AHCC) Improves Immunological Parameters and Performance Status of Patients with Solid Tumors. Biotherapy 2000;14(3):303-309.
Wakame K. Protective Effects of Active Hexose Correlated Compound (AHCC) on the Onset of Diabetes Induced by Streptozotocin in the Rat. Biomedical Research 1999;20(3):145-152.
Wakui, A., Kasai, M., Konno, K., Abe, R., Kanamaru, R., Takahashi, K., Nakai, Y., Yoshida, Y., Koie, H., Masuda, H., and . [Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group]. Gan To Kagaku Ryoho 1986;13(4 Pt 1):1050-1059. View abstract.
Wang, S., Ichimura, K., and Wakame, K. Preventive effects of active hexose correlated compound (AHCC) on oxidative stress induced by ferric nitrilotriacetate in the rat. Dokkyo Journal of Medical Sciences 2001;28(2-3):745-752.
Wang, S., Welte, T., Fang, H., Chang, G. J., Born, W. K., O'Brien, R. L., Sun, B., Fujii, H., Kosuna, K., and Wang, T. Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice. J Nutr. 2009;139(3):598-602. View abstract.
Wong, G. Y. C., Katdarae, M., Osborne, M. P., and Telang, N. T. Preventative efficacy of Lentinus edodes mycelium extract (LEM) in human mammary carcinogenesis (abstract 321). 19th Annual San Antonio Breast Cancer Symposium, (San Antonio, Texas) 1996;265.
Yagita, A., Maruyama, S., Wakasugi, S., and Sukegawa, Y. H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts. In Vivo 2002;16(1):49-54. View abstract.
Yamada, T., Watanabe, A., Sadou, S., Nishinuma, T., Tsurui, H., Watanabe, T., and Nakano, H. [A case of advanced gastric cancer with hepatic metastasis successfully treated by combined chemotherapy with UFT and lentinan]. Gan To Kagaku Ryoho 2000;27(2):281-284. View abstract.
Yamamoto, S., Takatori, K., Ohmoto, K., Ideguchi, S., Yamamoto, R., Ohumi, T., Hino, K., and Hirano, Y. [NK activity and T cell subsets in percutaneous ethanol injection therapy of liver cancer--effect of lentinan with combined use]. Gan To Kagaku Ryoho 1989;16(9):3291-3294. View abstract.
Yamamoto, Y., Shirono, H., Kono, K., and Ohashi, Y. Immunopotentiating activity of the water-soluble lignin rich fraction prepared from LEM--the extract of the solid culture medium of Lentinus edodes mycelia. Biosci.Biotechnol.Biochem. 1997;61(11):1909-1912. View abstract.
Yanagimoto, H., Satoi, S., Toyokawa, S., Yamamoto, T., Hirooka, S., Yamao, J., Araki, H., Matsui, Y., and Kwon, A. The Beneficial Effect of Active Hexose Correlated Compound (AHCC), a Health Food Component, in Patients with Pancreatic or Biliary Tract Cancer who Underwent Chemotherapy. Presented at the 40th APA (American Pancreatic Association) 2009.
Yang, P., Liang, M., Zhang, Y., and Shen, B. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Adv.Ther 2008;25(8):787-794. View abstract.
Ye, S. F., Wakame, K., Ichimura, K., and Matsuzaki, S. Amelioration by active hexose correlated compound of endocrine disturbances induced by oxidative stress in the rat. Endocr.Regul. 2004;38(1):7-13. View abstract.
Yin, G., Yu, J., and Li, D. [Immune modulatory and therapeutic effect of lentinan on condyloma acuminatum]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1998;18(11):665-667. View abstract.
Yin, Z., Fujii, H., and Walshe, T. Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-gamma and/or tumor necrosis factor-alpha in healthy adults. Hum.Immunol. 2010;71(12):1187-1190. View abstract.
Yoshino, S., Oka, M., Hazama, S., and Suzuki, T. [Effect of intrapleural and/or intraperitoneal lentinan therapy in carcinomatous pleuritis and peritonitis]. Gan To Kagaku Ryoho 1990;17(8 Pt 2):1588-1591. View abstract.
Yoshino, S., Oka, M., Hazama, S., and Suzuki, T. [Effect of intrapleural and/or intraperitoneal lentinan therapy on carcinomatous pleuritis and peritonitis with special reference to immunological evaluation]. Nippon Geka Hokan 5-1-1989;58(3):310-319. View abstract.
Yoshino, S., Tabata, T., Hazama, S., Iizuka, N., Yamamoto, K., Hirayama, M., Tangoku, A., and Oka, M. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers. Anticancer Res. 2000;20(6C):4707-4711. View abstract.
Zakany, J., Chihara, G., and Fachet, J. Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts. Int J Cancer 3-15-1980;25(3):371-376. View abstract.
Zhang, P. and Cheung, P. C. Evaluation of sulfated Lentinus edodes alpha-(1-->3)-D-glucan as a potential antitumor agent. Biosci.Biotechnol.Biochem. 2002;66(5):1052-1056. View abstract.
Zhang, X. H., Nishioka, H., and Fujii, H. Inhibitory Effect of AHCC and GCP on Upregulated CD133 and Nestin Expressions Induced by Norepinephrine in C6 Glioma Cells. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
Zheng, R., Jie, S., Hanchuan, D., and Moucheng, W. Characterization and immunomodulating activities of polysaccharide from Lentinus edodes. Int Immunopharmacol. 2005;5(5):811-820. View abstract.
Mendonça CN, Silva PM, Avelleira JC, Nishimori FS, Cassia Fde F. Shiitake dermatitis. An Bras Dermatol. 2015 Mar-Apr;90(2):276-8. View abstract.
Ade R, Sukut C, Wiser HJ, Shockman S, Buescher L. Shiitake dermatitis demonstrating Köebner phenomenon. Int J Dermatol. 2015;54(5):e179-81. View abstract.
Adler MJ, Larsen WG. Clinical variability of shiitake dermatitis. J Am Acad Dermatol. 2012 Oct;67(4):e140-1. View abstract.
Adriano AR, Acosta ML, Azulay DR, Quiroz CD, Talarico SR. Shiitake dermatitis: the first case reported in Brazil. An Bras Dermatol. 2013 May-Jun;88(3):417-9. View abstract.
Alagbaoso CA, Mizuno M. Lentinula edodes polysaccharides suppressed pro-inflammatory cytokines expression and colitis in mice. Arq Gastroenterol 2022;59(2):288-295. View abstract.
Ampere A, Delhaes L, Soots J, Bart F, Wallaert B. Hypersensitivity pneumonitis induced by Shiitake mushroom spores. Med Mycol. 2012 Aug;50(6):654-7. View abstract.
Arinaga S, Karimine N, Takamuku K, et al. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma. Int J Immunopharmac 1992;14:535-539. View abstract.
Baran W, Batycka-Baran A, Maj J, Szepietowski JC. Shiitake dermatitis - now also in Poland. Acta Derm Venereol. 2015 Jan;95(1):102-3. View abstract.
Boels D, Greillet C, Langrand J, et al. Shiitake dermatitis: experience of the Poison Control Centre Network in France from 2014 to 2019. Clin Toxicol (Phila) 2022. View abstract.
Boels D, Landreau A, Bruneau C, et al. Shiitake dermatitis recorded by French Poison Control Centers - new case series with clinical observations. Clin Toxicol (Phila). 2014 Jul;52(6):625-8. View abstract.
Booms A, Rashid Z, Al-Rubaie V, Bal A. Shiitake dermatitis: a case report of a rare mushroom-induced dermatitis in the United States. Int J Dermatol 2022. View abstract.
Chu EY, Anand D, Dawn A, Elenitsas R, Adler DJ. Shiitake dermatitis: a report of 3 cases and review of the literature. Cutis. 2013 Jun;91(6):287-90. View abstract.
Corazza M, Zauli S, Ricci M, et al. Shiitake dermatitis: toxic or allergic reaction? J Eur Acad Dermatol Venereol. 2015 Jul;29(7):1449-51. View abstract.
Czarnecka AB, Kreft B, Marsch WCh. Flagellate dermatitis after consumption of Shiitake mushrooms. Postepy Dermatol Alergol. 2014 Jun;31(3):187-90. View abstract.
Dai X, Stanilka JM, Rowe CA, et al. Consuming Lentinula edodes (Shiitake) Mushrooms Daily Improves Human Immunity: A Randomized Dietary Intervention in Healthy Young Adults. J Am Coll Nutr. 2015;34(6):478-87. View abstract.
deVere White RW, Hackman RM, Soares SE, et al. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 2002;60:640-4.. View abstract.
Elhusseiny SM, El-Mahdy TS, Elleboudy NS, Farag MMS, Aboshanab KM, Yassien MA. Immunomodulatory activity of extracts from five edible basidiomycetes mushrooms in Wistar albino rats. Sci Rep 2022;12(1):12423. View abstract.
Gordon M, Bihari B, Goosby E, et al. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. J Med 1998;29:305-30. View abstract.
Gordon M, Guralnik M, Kaneko Y, et al. A phase II controlled study of a combination of the immune modulator, lentinan, with didanosine (ddI) in HIV patients with CD4 cells of 200-500/mm3. J Med 1995;26:193-207. View abstract.
Hamer SE, Kulkarni K, Cohen SN. Shiitake dermatitis with oral ulceration and pustules. Clin Exp Dermatol. 2015 Apr;40(3):332-3. View abstract.
Hanada K, Hashimoto I. Flagellate mushroom (Shiitake) dermatitis and photosensitivity. Dermatol 1998;197:255-7. View abstract.
Hashimoto D, Satoi S, Yamamoto T, et al. Nutritional impact of active hexose-correlated compound for patients with resectable or borderline-resectable pancreatic cancer treated with neoadjuvant therapy. Surg Today 2021;51(11):1872-1876. View abstract.
Hiernickel C, Metz S, Elsner P. Shiitake dermatitis: an impressive case report. J Dtsch Dermatol Ges. 2015 May;13(5):455-6. View abstract.
Hitosugi M, Kitamura O, Takatsu A, Yoshino Y. Autopsy case of duodenal obstruction from impacted mushroom. J Gastroenterol 1998;33:562-5. View abstract.
Ishizuka, R., Fujii, H., Miura, T., Fukuchi, Y., and Tajima, K. Review of Cancer Therapy with AHCC® and GCP®; The Long-Term Follow-Up over 12 Years for Stage IV (M1) Cancer of the Lung and the Breast. INTERNATIONAL JOURNAL OF INTEGRATIVE MEDICINE 2010;2(1):98-111.
Kamiyama T, Orimo T, Wakayama K, et al. Preventing Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy With Active Hexose-correlated Compound Derived From Lentinula edodes Mycelia. Integr Cancer Ther 2022;21:15347354211073066. View abstract.
Karanovic S, George S, Topham E. Don't miss shiitake dermatitis: a case report. Br J Gen Pract. 2014 Aug;64(625):426-7. View abstract.
Kim H, Kim JH, Im JA. Effect of Active Hexose Correlated Compound (AHCC) in alcohol-induced liver enzyme elevation. J Nutr Sci Vitaminol (Tokyo). 2014;60(5):348-56. View abstract.
Kim HS, Kacew S, Lee BM. In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis miller, Lentinus edodes, Ganoderma lucidum and Coriolus versicolor). Carcinogenesis 1999;20:1637-40. View abstract.
Kopp T, Mastan P, Mothes N, Tzaneva S, Stingl G, Tanew A. Systemic allergic contact dermatitis due to consumption of raw shiitake mushroom. Clin Exp Dermatol. 2009 Dec;34(8):e910-3. View abstract.
Kosaka A, Kuzuoka M, Yamafuji K, et al. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans]. Gan To Kagaku Ryoho 1987;14:516-22. View abstract.
Kumar S, Singh A, Bajpai V, Srivastava M, Singh BP, Ojha S, Kumar B. Simultaneous Determination of Bioactive Monoterpene Indole Alkaloids in Ethanolic Extract of Seven Rauvolfia Species using UHPLC with Hybrid Triple Quadrupole Linear Ion Trap Mass Spectrometry. Phytochem Anal. 2016 Sep;27(5):296-303. View abstract.
Laurino LF, Viroel FJM, Caetano E, et al. Lentinus edodes exposure before and after fetus implantation: materno-fetal development in rats with gestational diabetes mellitus. Nutrients 2019;11(11):2720. doi: 10.3390/nu11112720. View abstract.
Levy AM, Kita H, Phillips SF, et al. Eosinophilia and gastrointestinal symptoms after ingestion of shiitake mushrooms. J Allergy Clin Immunol 1998;101:613-20. View abstract.
Lingström P, Zaura E, Hassan H, et al. The anticaries effect of a food extract (shiitake) in a short-term clinical study. J Biomed Biotechnol. 2012;2012:217164. View abstract.
Loo HV, Oon HH. Flagellate dermatitis following consumption of shiitake mushroom. Dermatol Reports. 2011 Oct 5;3(2):e21. View abstract.
Luber AJ, Ackerman LS. Flagellate shiitake mushroom dermatitis. Dermatol Online J. 2015 Aug 15;21(8). pii: 13030/qt7rm57553. View abstract.
Ma JY, Liu JW. Shiitake flagellate dermatitis. Mayo Clin Proc 2022;97(12):2192-2193. View abstract.
Malik MA, Jan Y, Al-Keridis LA, et al. Effect of vitamin-D-enriched edible mushrooms on vitamin D status, bone health and expression of CYP2R1, CYP27B1 and VDR gene in Wistar rats. J Fungi (Basel) 2022;8(8):864. View abstract.
Matsui S, Nakazawa T, Umegae Y, Mori M. Hypersensitivity pneumonitis induced by Shiitake mushroom spores. Intern Med 1992;31:1204-6. View abstract.
Matsuoka H, Seo Y, Wakasugi H, et al. Lentinan potentiates immunity and prolongs the survival time of some patients. Anticancer Res 1997;17:2751-5. View abstract.
Miyagishima D, Inoue M, Kinjo K, et al. A case of bowel obstruction due to shiitake mushrooms: Diagnostic features on computed tomography. Intern Med 2022. View abstract.
Murakami M, Kawabe K, Hosoi Y, et al. Decreased pulmonary perfusion in hypersensitivity pneumonitis caused by Shiitake mushroom spores. J Intern Med 1997;241:85-8. View abstract.
Nakamura T. Shiitake (Lentinus edodes) dermatitis. Contact Dermatitis 1992;27:65-70. View abstract.
Netchiporouk E, Pehr K, Ben-Shoshan M, Billick RC, Sasseville D, Singer M. Pustular flagellate dermatitis after consumption of shiitake mushrooms. JAAD Case Rep. 2015 May 2;1(3):117-9. View abstract.
Nguyen AH, Gonzaga MI, Lim VM, Adler MJ, Mitkov MV, Cappel MA. Clinical features of shiitake dermatitis: a systematic review. Int J Dermatol. 2017 Jun;56(6):610-616. View abstract.
Nishihira T, Akimoto M, Mori S. [Anti-cancer effects of BRMs associated with nutrition in cancer patients]. Gan To Kagaku Ryoho,1988;15:1615-20. View abstract.
Otsuka M, Shinozuka K, Hirata G, Kunitomo M. [Influences of a shiitake (Lentinus edodes)-fructo-oligosaccharide mixture (SK-204) on experimental pulmonary thrombosis in rats]. Yakugaku Zasshi 1996;116:169-73. View abstract.
Park S, Kim CJ, Ha KC, et al. Efficacy and safety of aronia, red ginseng, shiitake mushroom, and nattokinase mixture on insulin resistance in prediabetic adults: A randomized, double-blinded, placebo-controlled trial. Foods 2021;10(7):1558. View abstract.
Poppe LM, Anders D, Kneitz H, Bröcker EB, Benoit S. Flagellate dermatitis caused by shiitake mushrooms. An Bras Dermatol. 2012 May-Jun;87(3):463-5. View abstract.
Pravettoni V, Primavesi L, Piantanida M. Shiitake mushroom (Lentinus edodes): a poorly known allergen in Western countries responsible for severe work-related asthma. Int J Occup Med Environ Health. 2014 Oct;27(5):871-4. View abstract.
Ricar J, Pizinger K, Cetkovska P. Shiitake dermatitis: a distinctive clinical entity. Int J Dermatol. 2013 Dec;52(12):1620-1. View abstract.
Selective Androgen Receptor Modulators (SARMs) - A Prohibited Class of Anabolic Agents. U.S. Anti-Doping Agency, November 18, 2015. https://www.usada.org/selective-androgen-receptor-modulators-sarms-prohibited-class-anabolic-agencts/. Accessed: August 30, 2017.
Shozushima M, Ohata K, Nonaka K, Matsuhashi N. Shiitake mushroom-induced ileus managed using double-balloon enteroscopy. Endoscopy. 2013;45 Suppl 2 UCTN:E437. View abstract.
Smith JA, Gaikwad AA, Mathew L, et al. AHCC(®) Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections. Front Oncol 2022;12:881902. View abstract.
Soga K, Mukai H, Kitae H. Management of shiitake mushroom-induced ileus using balloon enteroscopy. Dig Endosc 2022;34(4):e58-e59. View abstract.
Spim SRV, Pistila AMH, Pickler TB, Silva MT, Grotto D. Effects of shiitake culinary-medicinal mushroom, Lentinus edodes (Agaricomycetes), bars on lipid and antioxidant profiles in individuals with borderline high cholesterol: A double-blind randomized clinical trial. Int J Med Mushrooms 2021;23(7):1-12. View abstract.
Sudy E, Urbina F. Shiitake dermatitis: clinical forms of presentation. Int J Dermatol 2023. View abstract.
Taguchi T. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey. Cancer Detect Prev Suppl 1987;1:333-49. View abstract.
Tan J, Yuan K, Zuo J, et al. Two cases of small bowel obstruction due to a shiitake mushroom. Gastroenterol Rep (Oxf) 2019;7(4):298-300. doi: 10.1093/gastro/gox028. View abstract.
Tari K, Satake I, Nakagomi K, et al. [Effect of lentinan for advanced prostate carcinoma]. Hinyokika Kiyo 1994;40:119-23. View abstract.
Turner J, Chaudhary U. Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer. Anticancer Drugs 2009;20:215-16. View abstract.
Ueda A, Obama K, Aoyama K, et al. Allergic contact dermatitis in shiitake (Lentinus edodes (Berk) Sing) growers. Contact Dermatitis 1992;26:228-33. View abstract.
Uslu U, Linkner RV. Shiitake mushroom dermatitis. Cutis. 2015 May;95(5):E11-2. View abstract.
Wada T, Nishide T, Hatayama K, et al. [A comparative clinical trial with tegafur plus lentinan treatment at two different doses in advanced cancer]. Gan To Kagaku Ryoho 1987;14:2509-11. View abstract.
Wang AS, Barr KL, Jagdeo J. Shiitake mushroom-induced flagellate erythema: A striking case and review of the literature. Dermatol Online J. 2013 Apr 15;19(4):5. View abstract.
Yanagimoto H, Hirooka S, Yamamoto T, Yamaki S, Sekimoto M. Efficacy of Lentinula edodes Mycelia Extract on Chemotherapy-Related Tasted Disorders in Pancreatic Cancer Patients. Nutr Cancer 2022. View abstract.
Ye SF, Ichimura K, Wakame K, Ohe M. Suppressive effects of Active Hexose Correlated Compound on the increased activity of hepatic and renal ornithine decarboxylase induced by oxidative stress. Life Sci 2003;74:593-602. View abstract.
Yoshiyuki T, Onda M, Tokunaga A, et al. [Treatment for peritoneal dissemination of gastric cancer by intraperitoneal administration of CDDP through Infuse-a-Port]. Gan To Kagaku Ryoho 1994;21:2323-5. View abstract.
Akimoto, M., Nishihira, T., and Kasai, M. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions]. Gan To Kagaku Ryoho 1986;13(4 Pt 2):1270-1276. View abstract.
Akimoto, M., Nishihira, T., and Mori, S. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments]. Gan To Kagaku Ryoho 1988;15(4 Pt 2-1):827-833. View abstract.
Select a condition to view a list of vitamins
You Might Also Like
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2020.